January 05, 2017
Nexstim to present at Biotech Showcase 9th Annual Conference in San Francisco
Media
January 05, 2017
Aprea Therapeutics Announces Presentation at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco
January 04, 2017
Strongbridge Biopharma plc to Present at Biotech Showcase 2017
January 04, 2017
Nordic Nanovector to Present at Biotech Showcase 2017
December 23, 2016
Strongbridge Biopharma plc Provides Corporate and Financial Update
December 23, 2016
Strongbridge Biopharma plc Announces Acquisition of U.S. Rights to KEVEYIS® From Taro
December 23, 2016
Strongbridge Biopharma plc Announces $35 Million Equity Financing
December 21, 2016
Nexstim Plc receives FDA’s response to the proposed limited size stroke trial plan
December 21, 2016
Björn Westberg to join BONESUPPORT™ as Chief Financial Officer
December 20, 2016
GenSight Biologics reports sustained visual acuity gain at 78 weeks in its Phase I/II Study with GS010 for the treatment of Leber’s Hereditary Optic Neuropathy (LHON)